BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX)

Historical Holders from Q4 2021 to Q4 2024

Symbol
BRTX on Nasdaq
CUSIP
090655606
Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
7.93M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
282K
Holdings value
$403K
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
15
Number of buys
4
Number of sells
-5
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ALSTODT LANCE 15.5% $1.97M 1.24M ALSTODT LANCE Feb 14, 2025
Silva Francisco 15.1% $1.9M 1.2M Silva, Francisco Feb 14, 2025
Auctus Fund Management LLC 9.9% $1.1M 692K Auctus Fund Management LLC Sep 30, 2024

Institutional Holders of BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 282K $403K +$6.04K $1.43 15
2024 Q3 270K $468K +$33.6K $1.74 15
2024 Q2 249K $506K -$192K $2.03 13
2024 Q1 384K $530K +$97.3K $1.38 12
2023 Q4 289K $499K -$133K $1.74 12
2023 Q3 363K $649K +$64.1K $1.79 14
2023 Q2 323K $1.42M +$123K $4.41 13
2023 Q1 299K $1.02M -$33.5K $3.40 14
2022 Q4 324K $890K -$94K $2.75 15
2022 Q3 358K $1.15M +$89.1K $3.22 12
2022 Q2 330K $973K -$47.6K $2.95 10
2022 Q1 345K $1.8M -$261K $5.23 9
2021 Q4 396K $1.72M +$1.23M $4.35 8